WallStSmart

Churchill Capital Corp XI (CCXI)vsIB Acquisition Corp. Common Stock (IBAC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

IBAC leads profitability with a 0.0% profit margin vs 0.0%. IBAC earns a higher WallStSmart Score of 25/100 (F).

CCXI

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 5.0Quality: 4.0
Piotroski: 2/9

IBAC

Avoid

25

out of 100

Grade: F

Growth: 3.7Profit: 4.0Value: 5.0Quality: 5.5
Piotroski: 3/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

IBAC0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$718.53M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

IBAC4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$54.64M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : IBAC

IBAC has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : IBAC

The primary concerns for IBAC are Revenue Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

IBAC is growing revenue faster at 0.0% — sustainability is the question.

CCXI generates stronger free cash flow (-157,581), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

IBAC scores higher overall (25/100 vs 23/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

IB Acquisition Corp. Common Stock

FINANCIAL SERVICES · SHELL COMPANIES · USA

IB Acquisition Corp. (Ticker: IBAC) is a special purpose acquisition company (SPAC) dedicated to uncovering high-growth prospects within the technology and consumer sectors. With a highly experienced management team at the helm, the company aims to forge transformative partnerships that drive stakeholder value and operational effectiveness. As an actively traded entity, IBAC offers institutional investors a strategic vehicle to gain exposure to emerging firms poised for explosive growth in a rapidly changing market landscape. By leveraging the momentum of SPAC transactions, IBAC is well-positioned to seize innovative investment opportunities that are expected to deliver substantial returns.

Want to dig deeper into these stocks?